Welcome to LookChem.com Sign In|Join Free
  • or
AP-237, also known as PX-237 or 2-aminopropane, is a synthetic research chemical that exhibits stimulant and euphoric effects. It functions as a potent dopamine and norepinephrine reuptake inhibitor, which contributes to its ability to enhance alertness, focus, and energy levels. Structurally, AP-237 resembles other stimulant drugs such as amphetamine and methamphetamine, yet it is noted for its more selective action on neurotransmitters. Classified as a novel psychoactive substance, AP-237 carries the risks of addiction, tolerance, and potential adverse impacts on cardiovascular and mental health. While it is under investigation for possible medical applications, its recreational use is fraught with significant health hazards and is often regulated by legal constraints.

17719-89-0

17719-89-0 Suppliers

This product is a nationally controlled contraband or patented product, and the Lookchem platform doesn't provide relevant sales information.

17719-89-0 Usage

Uses

Used in Pharmaceutical Research:
AP-237 is used as a research chemical for studying the effects of dopamine and norepinephrine reuptake inhibition on the central nervous system. Its application aids in understanding the mechanisms of action for stimulant drugs and their potential therapeutic uses.
Used in Neurotransmitter Modulation:
In the field of neuroscience, AP-237 is utilized to modulate neurotransmitter levels, specifically targeting the reuptake of dopamine and norepinephrine. This application is crucial for exploring the treatment of conditions related to neurotransmitter imbalances.
Used in Potential Medical Applications:
Although still under investigation, AP-237 is considered for potential medical applications due to its effects on alertness, focus, and energy. Its use in this context is aimed at developing treatments for disorders that may benefit from enhanced neurotransmitter activity.
Used in Legal and Regulatory Frameworks:
AP-237 is used as a case study in the development and enforcement of legal and regulatory frameworks surrounding novel psychoactive substances. Its classification and restrictions provide insights into the challenges of managing emerging recreational drugs and their health risks.

Check Digit Verification of cas no

The CAS Registry Mumber 17719-89-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,7,1 and 9 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 17719-89:
(7*1)+(6*7)+(5*7)+(4*1)+(3*9)+(2*8)+(1*9)=140
140 % 10 = 0
So 17719-89-0 is a valid CAS Registry Number.

17719-89-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Butyryl-4-cinnamylpiperazine

1.2 Other means of identification

Product number -
Other names 1-Butyryl-4-(3-phenyl-2-propenyl)piperazin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17719-89-0 SDS

17719-89-0Downstream Products

17719-89-0Relevant academic research and scientific papers

A Nickel(II)-Mediated Thiocarbonylation Strategy for Carbon Isotope Labeling of Aliphatic Carboxamides

Pedersen, Simon S.,Donslund, Aske S.,Mikkelsen, Jesper H.,Bakholm, Oskar S.,Papp, Florian,Jensen, Kim B.,Gustafsson, Magnus B. F.,Skrydstrup, Troels

supporting information, p. 7114 - 7123 (2021/03/03)

A series of pharmaceutically relevant small molecules and biopharmaceuticals bearing aliphatic carboxamides have been successfully labeled with carbon-13. Key to the success of this novel carbon isotope labeling technique is the observation that 13C-labeled NiII-acyl complexes, formed from a 13CO insertion step with NiII-alkyl intermediates, rapidly react in less than one minute with 2,2’-dipyridyl disulfide to quantitatively form the corresponding 2-pyridyl thioesters. Either the use of 13C-SilaCOgen or 13C-COgen allows for the stoichiometric addition of isotopically labeled carbon monoxide. Subsequent one-pot acylation of a series of structurally diverse amines provides the desired 13C-labeled carboxamides in good yields. A single electron transfer pathway is proposed between the NiII-acyl complexes and the disulfide providing a reactive NiIII-acyl sulfide intermediate, which rapidly undergoes reductive elimination to the desired thioester. By further optimization of the reaction parameters, reaction times down to only 11 min were identified, opening up the possibility of exploring this chemistry for carbon-11 isotope labeling. Finally, this isotope labeling strategy could be adapted to the synthesis of 13C-labeled liraglutide and insulin degludec, representing two antidiabetic drugs.